Insiders Psychemedics Corporation

Equities

PMD

US7443752057

Market Closed - Nasdaq Other stock markets 02:00:00 11/05/2024 am IST			5-day change	1st Jan Change
2.55 ^USD	-1.54%		0.00%	-13.85%

28/03	Psychemedics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
25/03	North American Morning Briefing : Tech in Focus on -2-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer	22/23/22	CI
Psychemedics Names Chief Revenue Officer	22/23/22	MT
Psychemedics Corporation Announces Charles Doucot, to Leave as Executive Vice President, Effective September 15, 2023	01/23/01	CI
Psychemedics Corporation Announces Board Changes	14/23/14	CI
Psychemedics Corporation Announces CEO Changes	14/23/14	CI
Psychemedics Says Brian Hullinger to Succeed Ray Kubacki as CEO, Effective Aug. 17	13/23/13	MT
Psychemedics Corporation Appoints William Norris as Controller of the Company, Effective as of January 1, 2023	31/22/31	CI
Psychemedics Corporation Announces Executive Changes	18/22/18	CI
Psychemedics Corporation Announces Retirement of Walter S. Tomenson, Jr. from Board	10/22/10	CI
Psychemedics Corporation Announces Board Changes	22/22/22	CI
Psychemedics Corporation Announces Board Changes	22/22/22	CI
Psychemedics Corporation Elects Robyn C. Davis on the Board of Director, Effective Immediately	18/21/18	CI
Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller	27/21/27	CI
Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel	17/20/17	CI
Psychemedics Corporation Announces Resignation of Neil L. Lerner as Its Vice President-Finance, Treasurer and Assistant Secretary of the Corporation, Effective November 27, 2020	17/20/17	CI
Psychemedics Corporation Promotes James Abely as Vice President and General Counsel	08/18/08	CI
Psychemedics Corporation Appoints Charles M. Doucot as Vice President, Sales and Marketing	02/18/02	CI
James V. Dyke Resigns as Corporate Vice President of Sales and Marketing of Psychemedics Corporation	14/17/14	CI
Psychemedics Corporation Appoints James P. Abely as Associate General Counsel	23/16/23	CI
Psychemedics Corporation Appoints A. Clinton Allen as Independent Board Member	17/15/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Psychemedics Corporation

Equities

PMD

US7443752057

Insiders

Filters